E. V. Zonova

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO) ALGORITHM FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IS APPLICABLE TO RUSSIAN CLINICAL PRACTICE: A CONSENSUS STATEMENT OF LEADING RUSSIAN AND ESCEO OSTEOARTHRITIS EXPERTS

L. N. Denisov, L. V. Menshikova, A. N. Torgashin et al. · Rheumatology Science and Practice · 2017 · 23 citations · Full text

Medicine, Clinical Sciences, Orthopedics +4

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY

E. P. Sharapova, E. Strebkova, E. V. Zonova · Rheumatology Science and Practice · 2018 · 14 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +9

The effect of olokizumab on rheumatoid arthritis patient’s reported outcomes: results of a double-blind randomized placebo-controlled multicenter phase III trial (CREDO 1)

E. V. Zonova, Sofia Kuzkina · Rheumatology Science and Practice · 2021 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17